|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
|
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Loss on common stock settlement | ||
| Depreciation and amortization | ||
| Stock-based compensation | ||
| Disposal of fixed assets | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | ||
| Other long-term assets | ||
| Accounts payable | ||
| Accrued expenses | ||
| Net cash used in operating activities | ||
| Accrued indemnification obligation | ||
| Net cash used in operating activities, Total | ||
| Cash flows from investing activities | ||
| Capital expenditures | ||
| Net cash used in investing activities | ||
| Net cash used in investing activities, Total | ||
| Net Cash Provided by (Used in) Financing Activities | ||
| Proceeds from exercise of stock options | ||
| Shares surrendered for taxes | ||
| Proceeds from exercise of stock warrants | ||
| Payments of deferred IPO costs | ||
| Net cash provided by financing activities | ||
| Proceeds from IPO and Follow-On Offering, net of issuance costs | ||
| Net cash provided by financing activities, Total | ||
| Net (decrease) increase in cash and cash equivalents | ||
| Cash and cash equivalents, beginning of period | ||
| Cash and cash equivalents, end of period | ||
| Supplemental cash flow information: | ||
| Capital expenditures in accounts payable and accrued liabilities | ||
| Deferred issuance costs for underwritten offering in accounts payable and accrued liabilities |
Loading...
